Faux Pas Recognition and Executive Processes in Patients with Alcohol Use Disorder: Toward an Investigation of Interindividual Heterogeneity.

Alcohol use disorder Executive functions Faux pas Neuropsychology Social functioning Theory of mind

Journal

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
ISSN: 1873-5843
Titre abrégé: Arch Clin Neuropsychol
Pays: United States
ID NLM: 9004255

Informations de publication

Date de publication:
22 Feb 2022
Historique:
accepted: 24 08 2021
pubmed: 17 9 2021
medline: 27 4 2022
entrez: 16 9 2021
Statut: ppublish

Résumé

Impairment of executive functions (EF) has been documented for decades in patients with alcohol use disorders (AUD), while more recent studies have also reported impaired theory of mind. Both have been associated with negative outcomes, particularly a high risk of relapse. However, the interrelatedness of EF and theory of mind impairments remains subject to debate. About 19 AUD outpatients and 20 healthy controls (HC) were asked to complete measures of motor inhibition, mental flexibility, and updating to assess EF, and the faux pas test to assess theory of mind. As expected, patients' mean performances on EF and faux pas measures were poorer than those of HC. Correlational analyses revealed that executive processes were differentially related to faux pas subscores. Additional single-case analyses corroborated the strong association between EF and faux pas interpretation, as patients with AUD mostly had congruent performances (i.e., both EF and faux pas impaired or both EF and faux pas preserved). This study highlights the interrelatedness of EF and faux pas performances in AUD, but also emphasizes the incomplete overlap of the cognitive processes involved in these tasks, with heterogeneous patterns of association. Based on these findings, tailored cognitive rehabilitation programs that simultaneously target EF and faux pas recognition could be developed to favor patients' social inclusion and reduce the risk of relapse. Results also argue in favor of systematic screening for EF and theory of mind impairments among AUD patients.

Identifiants

pubmed: 34530445
pii: 6371355
doi: 10.1093/arclin/acab072
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

608-620

Subventions

Organisme : University of Reims Champagne-Ardenne

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Franca Schmid (F)

Université de Reims Champagne Ardenne, Laboratoire Cognition, Santé, Société (C2S), Reims, France.

Franklin Moreau (F)

Université de Reims Champagne Ardenne, Laboratoire Cognition, Santé, Société (C2S), Reims, France.

Farid Benzerouk (F)

Université de Reims Champagne Ardenne, Laboratoire Cognition, Santé, Société (C2S), Reims, France.
Psychiatry Department, Reims University Hospital, Marne Mental Health Institute, Reims, France.

Delphine Raucher-Chéné (D)

Université de Reims Champagne Ardenne, Laboratoire Cognition, Santé, Société (C2S), Reims, France.
Psychiatry Department, Reims University Hospital, Marne Mental Health Institute, Reims, France.
Douglas Mental Health University Institute, McGill University, Montreal, Canada.

Arthur Kaladjian (A)

Université de Reims Champagne Ardenne, Laboratoire Cognition, Santé, Société (C2S), Reims, France.
Psychiatry Department, Reims University Hospital, Marne Mental Health Institute, Reims, France.

Fabien Gierski (F)

Université de Reims Champagne Ardenne, Laboratoire Cognition, Santé, Société (C2S), Reims, France.
Psychiatry Department, Reims University Hospital, Marne Mental Health Institute, Reims, France.
Research Group on Alcohol and Drug Dependence (GRAP), INSERM-University of Picardy Jules Verne, Amiens, France.

Audrey Henry (A)

Université de Reims Champagne Ardenne, Laboratoire Cognition, Santé, Société (C2S), Reims, France.
Psychiatry Department, Reims University Hospital, Marne Mental Health Institute, Reims, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH